Javascript must be enabled to continue!
TMEM98 is a negative regulator of FRAT mediated Wnt/β-catenin signalling
View through CrossRef
Summary
Wnt/β-catenin signalling is crucial for maintaining the balance between cell proliferation and differentiation, both during tissue morphogenesis and during tissue maintenance in postnatal life. Whereas the signalling activities of the core Wnt/β-catenin pathway components are understood in great detail, far less is known about the precise role and regulation of the many different modulators of Wnt/β-catenin signalling that have been identified to date.
Here we describe TMEM98, a putative transmembrane protein of unknown function, as an interaction partner and regulator of the GSK3-binding protein FRAT2. We show that TMEM98 reduces FRAT2 protein levels and, accordingly, inhibits the FRAT2-mediated induction of β-catenin/TCF signalling. We also characterize the intracellular trafficking of TMEM98 in more detail and show that it is recycled between the plasma membrane and the Golgi. Together, our findings not only reveal a new layer of regulation for Wnt/β-catenin signalling, but also a new biological activity for TMEM98.
Title: TMEM98 is a negative regulator of FRAT mediated Wnt/β-catenin signalling
Description:
Summary
Wnt/β-catenin signalling is crucial for maintaining the balance between cell proliferation and differentiation, both during tissue morphogenesis and during tissue maintenance in postnatal life.
Whereas the signalling activities of the core Wnt/β-catenin pathway components are understood in great detail, far less is known about the precise role and regulation of the many different modulators of Wnt/β-catenin signalling that have been identified to date.
Here we describe TMEM98, a putative transmembrane protein of unknown function, as an interaction partner and regulator of the GSK3-binding protein FRAT2.
We show that TMEM98 reduces FRAT2 protein levels and, accordingly, inhibits the FRAT2-mediated induction of β-catenin/TCF signalling.
We also characterize the intracellular trafficking of TMEM98 in more detail and show that it is recycled between the plasma membrane and the Golgi.
Together, our findings not only reveal a new layer of regulation for Wnt/β-catenin signalling, but also a new biological activity for TMEM98.
Related Results
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Abstract
Abstract 1851
Background:
The proteasome inhibitor Bortezomib (Bz) shows significant activity in Multipl...
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract
Clinical evidence suggests that β-catenin accumulation in breast cancer is associated with poor prognosis. Accumulation of β-catenin occurs even though acti...
Abstract 3820: Wnt signaling and telomerase activation in hepatoblastoma.
Abstract 3820: Wnt signaling and telomerase activation in hepatoblastoma.
Abstract
Purpose: The abnormal Wnt/β-catenin signaling plays a key role in hepatoblastoma (HBL) development. In HBL, CTNNB1 coding ß-catenin protein with mutated or ...
Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
Abstract
Background
Neuroinflammatory pathways are emerging therapeutic targets for neurological conditions such as Parkinson’s...
Identification of Wnt regulated genes that are repressed by, or independent of, β-catenin
Identification of Wnt regulated genes that are repressed by, or independent of, β-catenin
Abstract
Wnt signaling regulates metazoan development and homeostasis, in part by β-catenin dependent activation and repression of a large number of genes. However,...
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract
Carcinogenesis is often accelerated by the aberrant activation of components molecules of Wnt signaling pathway, especially, APC and beta-catenin are freque...
WNT-mediated regulation of regeneration and oncogenesis
WNT-mediated regulation of regeneration and oncogenesis
WNT signaling is a key cell-cell communication pathway that regulates essential cellular processes such as cell fate determination and proliferation. Accordingly, WNT signaling pla...
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract
Background: Prostate cancer (PCa) is the leading cancer among men in the world. Androgen deprivation therapy is a common treatment to cease prostate growth....

